Cytokine & Growth Factor Reviews

Papers
(The median citation count of Cytokine & Growth Factor Reviews is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Editorial Board271
Corrigendum to “Ferroptosis in immune cells: Implications for tumor immunity and cancer therapy” [Cytokine Growth Factor Rev. 84 (2025) 59–73]148
Unveiling cytokine charge disparity as a potential mechanism for immune regulation143
Navigating IL-6: From molecular mechanisms to therapeutic breakthroughs130
Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions130
COVID-19: From emerging variants to vaccination119
Editorial Board117
CDK4/6 inhibition in hormone receptor-positive/HER2-negative breast cancer: Biological and clinical aspects89
Editorial Board87
Editorial Board84
Proteomics analysis of circulating small extracellular vesicles: Focus on the contribution of EVs to tumor metabolism81
Erratum to “TLR-Based therapeutic strategies for Hepatocellular carcinoma” [Cytokine Growth Factor Rev. Volume 85 2025 Pages 179–189]80
Metabolic Regulation of cGAS-STING Signaling in the Tumor Microenvironment: Dual Immune Roles and Therapeutic Implications75
Insights into IL-6/JAK/STAT3 signaling in the tumor microenvironment: Implications for cancer therapy74
Progranulinopathy: A diverse realm of disorders linked to progranulin imbalances71
Targeting cytokines: Reshaping the pancreatic tumor microenvironment68
Natural killers or natural regulators? Dual roles of NK cells in checkpoint immunotherapy62
Epithelial-to-mesenchymal transition transcription factors: New strategies for mesenchymal tissue regeneration58
Molecular mechanisms of regulation of IL-1 and its receptors55
Editorial Board49
Immuno-metabolic control of the balance between Th17-polarized and regulatory T-cells during HIV infection48
Novel insights into neuroinflammatory mechanisms in traumatic brain injury: Focus on pattern recognition receptors as therapeutic targets48
Cytokine symphony: Deciphering the tumor microenvironment and metastatic axis in oral cancer48
TGF-β mediated drug resistance in solid cancer47
Central role of Galectin-3 at the cross-roads of cardiac inflammation and fibrosis: Implications for heart failure and transplantation47
Exogenous drug-induced mouse models of atopic dermatitis47
The immunodynamics of pulmonary fibrosis46
Chemokines and chemokine receptors: Insights from human disease and experimental models of helminthiasis46
The cGAS-STING pathway: Post-translational modifications and functional implications in diseases43
Scarless wound healing: Current insights from the perspectives of TGF-β, KGF-1, and KGF-243
Immunosuppressive tumor microenvironment and uterine fibroids: Role in collagen synthesis43
Exosomes: Another intercellular lipometabolic communication mediators in digestive system neoplasms?42
MDSCs might be “Achilles heel” for eradicating CSCs42
Exosomes as a modulator of immune resistance in human cancers42
The role of neurotransmitter signaling in colorectal cancer progression: Opportunities for drug repurposing40
Tumor microenvironment, histone modifications, and myeloid-derived suppressor cells40
Editorial Board40
Post COVID-19 pandemic Inflammatory Insights into Cancer: Consequences for immunotherapy40
Multifaceted role of CD14 in innate immunity and tissue homeostasis40
Targeting the NLRP3 inflammasome in sepsis: Molecular mechanisms and therapeutic strategies39
Decoding the roles of heat shock proteins in liver cancer39
The roles of cell-cell and organ-organ crosstalk in the type 2 diabetes mellitus associated inflammatory microenvironment38
Modulation of IL-33/ST2 signaling as a potential new therapeutic target for cardiovascular diseases38
Quantitative and qualitative differences in the activation of a fibroblast growth factor receptor by different FGF ligands37
Exploring inflammatory and fibrotic mechanisms driving diabetic nephropathy progression37
Forgetting COVID-19 – Introduction to the special issue36
From senescence to scarring: Exploring TGF-β signaling in cellular aging, fibrotic remodeling, and pulmonary fibrosis35
The impact of adipokines on vascular networks in adipose tissue35
Nuclear translocation of RON receptor tyrosine kinase. New mechanistic and functional insights35
Exosomal noncoding RNA-mediated spatiotemporal regulation of lipid metabolism: Implications in immune evasion and chronic inflammation33
The role of Extracellular Vesicles in glycolytic and lipid metabolic reprogramming of cancer cells: Consequences for drug resistance31
mTOR in programmed cell death and its therapeutic implications31
Role of exosomes in transferring chemoresistance through modulation of cancer glycolytic cell metabolism31
Therapeutic inhibition of the JAK-STAT pathway in the treatment of inflammatory bowel disease31
Liquid biopsy analysis of lipometabolic exosomes in pancreatic cancer30
Extracellular vesicles: Emerging mediators of cell communication in gastrointestinal cancers exhibiting metabolic abnormalities30
Ferroptosis in immune cells: Implications for tumor immunity and cancer therapy30
Editorial Board29
Glioblastoma-associated macrophages: A key target in overcoming glioblastoma therapeutic resistance29
Spatiotemporal dynamic regulation of the CX3CL1-CX3CR1 axis: A double-edged sword in the tumor immune microenvironment and new strategies for precision therapy28
Exosomes-regulated lipid metabolism in tumorigenesis and cancer progression28
Cholecystokinin and gastrin as immune modulating hormones: Implications and applications28
Nefarious NTRK oncogenic fusions in pediatric sarcomas: Too many to Trk28
Cancer-associated fibroblasts: Vital suppressors of the immune response in the tumor microenvironment27
Interleukin-17: A pleiotropic cytokine implicated in inflammatory, infectious, and malignant disorders27
Crosstalk between lncRNAs in the apoptotic pathway and therapeutic targets in cancer26
The IL-2A receptor pathway and its role in lymphocyte differentiation and function26
The critical role of osteopontin (OPN) in fibrotic diseases25
Regulation of regulated cell death by extracellular vesicles in acute kidney injury and chronic kidney disease25
JAK inhibitors in immune regulation and treatment of vitiligo25
The intricate relationship between cytokines and galectins in immune modulation25
The journey of STING: Guiding immune signaling through membrane trafficking24
Multiple post-translational modifications ensure EGFR functionality: Potential therapeutic targets to overcome its drug-resistance mutations24
Alternative pathways driven by STING: From innate immunity to lipid metabolism24
Mechanisms and routes of G-protein coupled receptor-mediated Tau degradation in Alzheimer’s disease24
Unraveling the intricacies of neutrophil extracellular traps in inflammatory bowel disease: Pathways, biomarkers, and promising therapies24
cPLA2 in musculoskeletal and autoimmune diseases: Molecular mechanisms and therapeutic insights24
Uncovering key mechanisms and intervention therapies in aging skin23
Could IL-25 be a potential therapeutic target for intestinal inflammatory diseases?23
Editorial Board23
The functional roles of m6A modification in T lymphocyte responses and autoimmune diseases22
Macrophage migration inhibitor factor (MIF): Potential role in cognitive impairment disorders22
Retard or exacerbate: Role of long non-coding RNA growth arrest-specific 5 in the fibrosis22
T cell receptor signaling in the differentiation and plasticity of CD4+ T cells21
Leptin as a mechanistic link between obesity and systemic lupus erythematous21
Decoding the neuroimmune axis in colorectal cancer: From neural circuitry to therapeutic innovation21
The activin-follistatin system: Key regulator of kidney development, regeneration, inflammation, and fibrosis20
Endothelial and macrophage interactions in the angiogenic niche20
GLP-1R agonist therapy and vaccine response: Neglected implications20
The anti-inflammatory effects of itaconate and its derivatives in neurological disorders19
An emerging paradigm of CXCL16 involvement in cancer progression19
LC3B: A microtubule-associated protein influences disease progression and prognosis18
Pharmacological therapies and drug development targeting SARS-CoV-2 infection18
Bacterial immunomodulatory structures as determinants of the maternal immune response and autism risk18
Tightly bound T-cell clusters: A new class of hyper-effector tumor killers17
Exosome-mediated metabolic reprogramming: Implications in esophageal carcinoma progression and tumor microenvironment remodeling17
Role of cytokine-based immunotherapy approaches in gastrointestinal cancers16
Immune evasion of neutralizing antibodies by SARS-CoV-2 Omicron16
Cytokines and soluble mediators as architects of tumor microenvironment reprogramming in cancer therapy16
Cytokines on the way to secretion16
Interleukin-33/serum stimulation-2 pathway: Regulatory mechanisms and emerging implications in immune and inflammatory diseases15
The central role of CXCL10-CXCR3 signaling in neuroinflammation and neuropathology15
Recent progress and prospects for anti-cytokine therapy in preclinical and clinical acute lung injury15
The impact of cytokines in neuroinflammation-mediated stroke15
Role of lipid signalling in extracellular vesicles-mediated cell-to-cell communication15
Assessment of clinical studies evaluating combinations of immune checkpoint inhibitors with locoregional treatments in solid tumors15
Pancreatic cancer exosomes: Their role in drug resistance and immunomodulation15
GDF15 in the tumor microenvironment: A central mediator of cancer immunometabolism and therapeutic resistance14
Meteorin-like/Metrnl: A pleiotropic cytokine implicated in metabolic, inflammatory and malignant disorders14
Role of growth factors and their interplay during oligodendroglial differentiation and maturation14
Glycosylation of FGF/FGFR: An underrated sweet code regulating cellular signaling programs14
Extracellular vesicles as mediators of cell-cell communication in ovarian cancer and beyond – A lipids focus14
The involvement of TH17 cells in the pathogenesis of IBD13
Editorial Board13
Unveiling the role of IL-17: Therapeutic insights and cardiovascular implications13
Mechanisms of NLRP3 inflammasome activation and the development of peptide inhibitors13
Targeting interleukin-17 in radiation-induced toxicity and cancer progression13
The odyssey of cGAS: From cytosol to nucleus13
BCR-ABL: The molecular mastermind behind chronic myeloid leukemia12
Neuroprotective properties of ciliary neurotrophic factor in the retina for the treatment of macular telangiectasia type 212
The role of microglial activation on ischemic stroke: Modulation by fibroblast growth factors12
Chemokines in thyroid cancer: Mechanistic insights and clinical implications12
TLR-based therapeutic strategies for hepatocellular carcinoma11
Granulocyte macrophage colony stimulating factor in virus-host interactions and its implication for immunotherapy11
Preexisting immunity: Barrier or bridge to effective oncolytic virus therapy?11
Inflammation and Type 1 interferon signaling in pancreatic adenocarcinoma: Insights into inflammasome driven crosstalk and therapeutic advances11
Cardiac and pericardial inflammatory changes and post-cardiac surgery atrial fibrillation10
Adeno-associated virus therapies: Pioneering solutions for human genetic diseases10
Extracellular vesicles in cardiovascular diseases: From pathophysiology to diagnosis and therapy10
The evolving epidemiology of monkeypox virus10
The IL-17 axis in gastric carcinogenesis: From inflammation to oncogenic transformation10
Protein-protein interactions and related inhibitors involved in the NLRP3 inflammasome pathway10
Neuro-endocrine-immune regulation of metabolic homeostasis10
Acinar cells and the development of pancreatic fibrosis10
Nanotechnology-based cytokine delivery strategies in gastrointestinal cancers10
0.13349390029907